FDA Extends Enforcement Discretion On Free Phytosterol Health Claims
This article was originally published in The Pink Sheet Daily
Executive Summary
Firms now have a year to drop claims of reduced risk for coronary heart disease for free-form phytosterols, which are more frequently used to make supplements because they are less bulky and facilitate the production of smaller, easier-to-swallow pills, or reformulate their products.